Zimmer Biomet Inc. (ZBH)
NYSE: ZBH
· Real-Time Price · USD
102.00
0.18 (0.18%)
At close: May 02, 2025, 3:59 PM
105.47
3.40%
Pre-market: May 05, 2025, 05:20 AM EDT
0.18% (1D)
| Bid | 99.68 |
| Market Cap | 20.18B |
| Revenue (ttm) | 7.68B |
| Net Income (ttm) | 903.9M |
| EPS (ttm) | 4.43 |
| PE Ratio (ttm) | 23.02 |
| Forward PE | 11.51 |
| Analyst | Hold |
| Ask | 105.48 |
| Volume | 2,628,601 |
| Avg. Volume (20D) | 2,040,325 |
| Open | 102.78 |
| Previous Close | 101.82 |
| Day's Range | 101.07 - 103.03 |
| 52-Week Range | 93.10 - 122.25 |
| Beta | 0.84 |
About ZBH
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices an...
Industry Medical - Devices
Sector Healthcare
IPO Date Jul 25, 2001
Employees 17,000
Stock Exchange NYSE
Ticker Symbol ZBH
Website https://www.zimmerbiomet.com
Analyst Forecast
According to 22 analyst ratings, the average rating for ZBH stock is "Hold." The 12-month stock price forecast is $120, which is an increase of 17.65% from the latest price.
Stock ForecastsNext Earnings Release
Zimmer Biomet Inc. is scheduled to release its earnings on May 5, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
6 months ago
+5.71%
Zimmer Biomet Holdings shares are trading higher a...
Unlock content with
Pro Subscription
8 months ago
-8.74%
Zimmer Biomet shares are trading lower amid reports the company said the newly implemented ERP will likely impact revenue this year.
